M&A Deal Summary |
|
|---|---|
| Date | 2014-09-16 |
| Target | AVEye Biotechnologie |
| Sector | Leisure |
| Buyer(s) | Nicox |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1996 |
| Sector | Life Science |
| Employees | 28 |
| Revenue | 8M EUR (2024) |
Nicox is an international company focused on the ophthalmic market. With a heritage of innovative R&D, business development and commercial expertise, the Nicox team is building a diversified portfolio of therapies and diagnostic tools that can help people to enhance their sight. Nicox was founded in 1996 and is based in Biot, France.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 4 |
| Sector: Leisure M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 3 of 4 |
| Country: Austria M&A | 1 of 1 |
| Year: 2014 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-09-16 |
Laboratoires Doliage
Suresnes, France Laboratoires Doliage is an ophthalmic company. |
Buy | $7M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-10-24 |
Aciex Therapeutics
Boston, Massachusetts, United States Aciex Therapeutics, Inc. is an ophthalmic pharmaceutical company centered on developing first in class products to treat ocular diseases. |
Buy | $120M |
